{
    "Trade/Device Name(s)": [
        "xTAG Respiratory Viral Panel",
        "xTAG RVP"
    ],
    "Submitter Information": "Luminex Molecular Diagnostics Inc.",
    "510(k) Number": "K091667",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063765",
        "K081483"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OEM",
        "OEP"
    ],
    "Summary Letter Date": "June 25, 2009",
    "Summary Letter Received Date": "June 9, 2009",
    "Submission Date": "June 3, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza A subtype H1",
        "Influenza A subtype H3",
        "Influenza B",
        "Respiratory Syncytial Virus subtype A",
        "Respiratory Syncytial Virus subtype B",
        "Parainfluenza 1",
        "Parainfluenza 2",
        "Parainfluenza 3",
        "Human Metapneumovirus",
        "Rhinovirus",
        "Adenovirus"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "xTAG Data Analysis Software (TDAS RVP-I)"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex PCR",
        "Target specific primer extension (TSPE)",
        "Nucleic acid multiplex assay"
    ],
    "Methodologies": [
        "PCR-based nucleic acid detection",
        "Multiplex molecular testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Multiplex",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for xTAG Respiratory Viral Panel multiplex PCR assay for detection of respiratory viruses in nasopharyngeal swabs",
    "Indications for Use Summary": "Qualitative multiplex nucleic acid assay for simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs from individuals suspected of respiratory tract infections, to aid diagnosis in conjunction with clinical and laboratory findings.",
    "fda_folder": "Microbiology"
}